Sourced guides
Read the day. Understand the night.
Understand hot-flash outcomes, night sweats, sleep and medicine-specific safety. Each guide includes sources and questions to take into a clinical conversation.
Fewer flashes, milder flashes, easier days: three different treatment goals
A hot-flash count, an intensity rating and an account of interrupted life answer different questions. Keep all three visible when discussing relief.
Night sweats and sleep: describe the waking, not just the heat
Separate heat-related awakenings, trouble returning to sleep and daytime tiredness before assuming one menopause treatment will resolve them all.
Nonhormonal treatment still needs a medicine-specific safety review
Paroxetine, fezolinetant and elinzanetant have different interactions, precautions and follow-up duties. Do not combine them into one safety profile.
Read a hot-flash treatment claim in six questions
Who was studied, compared with what, measuring which outcome, for how long, using which exact product—and what does the claim leave unresolved?
Paroxetine Hot-Flash Trials: Nighttime Awakenings and Sleep Duration
Two placebo-controlled trials support low-dose paroxetine for menopausal hot flashes. Their sleep analysis found modest additional gains in nighttime waking and sleep duration, with important differences across outcomes.
SKYLIGHT 1: Fezolinetant Symptom Results and Current Liver-Safety Evidence
The 527-participant randomized trial established a benefit for hot-flash frequency and severity over 12 weeks. Its extension, separate sleep research, and current boxed liver warning answer different questions.